Long-Term Clinical Outcomes of HSCT in MS
Long-Term Clinical Outcomes of HSCT in MS
Neurology. 2021 Jan 20;10.1212/WNL.0000000000011461.
Objective: To determine whether autologous hematopoietic stem cell transplantation (aHSCT) is able to induce durable disease remission in people with multiple sclerosis (MS), we analyzed the long-term outcomes after transplant in a large cohort of MS patients.
Methods: To be included, a minimum data set (consisting of age, MS phenotype, EDSS at baseline, information on transplant technology and at least 1 follow-up visit after transplant) was required.
Results: 210 patients were included [relapsing-remitting (RR)MS=122(58%)]. Median baseline EDSS was 6(1-9), mean follow-up was 6.2(±5.0) years. Among RRMS patients, disability worsening-free survival (95%CI) was 85.5%(76.9-94.1%) at 5 years and 71.3%(57.8-84.8%) at 10 years. In patients with progressive MS, disability worsening-free survival was 71.0%(59.4-82.6%) and 57.2%(41.8-72.7%) at 5 and 10 years, respectively. In RRMS patients, EDSS significantly reduced after aHSCT [p=0.001; mean EDSS change per year -0.09 (95%CI=-0.15 to -0.04%)]. In RRMS patients, the use of the BEAM+ATG conditioning protocol was independently associated with a reduced risk of NEDA-3 failure [HR=0.27(0.14-0.50), p<0.001]. Three patients died within 100-days from aHSCT (1.4%); no deaths occurred in patients transplanted after 2007.
Conclusions: aHSCT prevents disability worsening in the majority of patients and induces durable improvement in disability in patients with RRMS. The BEAM+ATG conditioning protocol is associated with a more pronounced suppression of clinical relapses and MRI inflammatory activity.
Classification of evidence: This study provides Class IV evidence that for people with MS, aHSCT induces durable disease remission in most patients.
Re: Long-Term Clinical Outcomes of HSCT in MS
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 294 Views
-
Last post by TheMSCookbook
Mon Sep 28, 2020 9:14 pm
-
- 3 Replies
- 386 Views
-
Last post by Scott1
Mon Jan 04, 2021 7:15 pm
-
-
Clinical course can be predicted
by frodo » Thu Jul 30, 2020 11:49 pm » in MS Etiology and Pathogenesis - 0 Replies
- 229 Views
-
Last post by frodo
Thu Jul 30, 2020 11:49 pm
-
-
- 0 Replies
- 829 Views
-
Last post by Petr75
Tue May 21, 2019 7:58 am
-
- 2 Replies
- 1162 Views
-
Last post by Emi87
Sat May 16, 2020 4:48 am
-
-
MS clinical types are obsolete
by frodo » Sun Dec 08, 2019 4:57 am » in MS Etiology and Pathogenesis - 0 Replies
- 683 Views
-
Last post by frodo
Sun Dec 08, 2019 4:57 am
-
-
-
biological MS begins 6 years before clinical MS
by frodo » Mon Sep 16, 2019 7:05 am » in MS Etiology and Pathogenesis - 0 Replies
- 946 Views
-
Last post by frodo
Mon Sep 16, 2019 7:05 am
-
-
- 0 Replies
- 1060 Views
-
Last post by Vivianne766
Wed Sep 18, 2019 5:08 pm
-
-
Report against division of MS in clinical types
by frodo » Wed Apr 03, 2019 6:56 am » in MS Etiology and Pathogenesis - 0 Replies
- 553 Views
-
Last post by frodo
Wed Apr 03, 2019 6:56 am
-